Overview

IMRT Combined With Toripalimab in Unresectable Locally Recurrent Nasopharyngeal Carcinoma.

Status:
Recruiting
Trial end date:
2020-10-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of intensity-modulated radiation therapy combined with toripalimab in patients with the unresectable locally recurrent nasopharyngeal carcinoma.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Sun Yat-sen University